NCT00932867View on ClinicalTrials.gov

Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment

CompletedOBSERVATIONAL
Enrollment

3,114

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

August 31, 2009

Conditions
Hypertension
Interventions
DRUG

Kinzal/Pritor (Telmisartan, BAY68-9291)

Patients under daily life treatment receiving Pritor according to local drug information.

Trial Locations (2)

Unknown

Many Locations

Many Location

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT00932867 - Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment | Biotech Hunter | Biotech Hunter